Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPembroke Vct Regulatory News (PEMB)

Share Price Information for Pembroke Vct (PEMB)

Share Price is delayed by 15 minutes
Get Live Data
92.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 4.00 (4.444%)
Market Cap: £269.20m
PEMB Live PriceLast checked at - London Stock Exchange

Intraday Pembroke Vct Share Chart

Directorate Change

28 Aug 2018 17:00

RNS Number : 0167Z
Pembroke VCT PLC
28 August 2018
 

 

Pembroke VCT plc (the "Company")

 

Director changes

 

The Board of the Company is pleased to announce the appointment of David Till as a non-executive director of the Company with effect from 28 August 2018.

 

David Till co-founded the Oakley Capital Group in 2002 with Peter Dubens. David plays a key role within the group and has overall responsibility for operations, finance, due diligence, compliance and fund formation. Oakley Capital Private Equity invests in and supports the continued growth and development of some of Europe's leading companies and seeks to build long-term relationships with talented entrepreneurial founders and managers. Over the past ten years Oakley has built expertise in three core sectors: TMT, Digital Consumer and Education, and has strong credentials and networks in these areas. Oakley Capital comprises three mid-market private equity funds comprising Fund I (€288 million), Fund II (€524 million) and Fund III which closed at €800 million in September 2017. The Funds generate strong returns for their limited partners as well as Oakley Capital Investments Limited, an AIM listed investment vehicle that invests in Oakley's private equity funds.

 

David holds a BA (Hons) in Economics from Essex University. He started his career in the British Army, then later qualified as a chartered accountant with Coopers & Lybrand, worked in industry as a finance director before returning to the profession holding senior M&A roles.

 

The Board also announces that Peter Dubens retires as a director of the Company on 28 August 2018.

 

 

For further details about the Company please either visit the Company's website:

 

Pembroke VCT plc

www.pembrokevct.com

 

or contact:

 

Pembroke VCT plc or Oakley Investment Managers LLP (Manager)

+44 20 7766 6900

Andrew Wolfson/Tamara Warren

 

Cornerstone Communications

+44 7917 080 365

Richard Acworth

 

The City Partnership (UK) Limited (Company Secretary)

+44 131 510 7465

Doreen Nic

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOALLFEITLITFIT
Date   Source Headline
29th May 20264:00 pmRNSTotal Voting Rights
29th May 202610:30 amRNSIssue of Equity
28th May 202612:30 pmRNSNotification of Admission of Shares
11th May 20267:00 amRNSClose of Offer to Further Applications
30th Apr 20264:00 pmRNSNotification of Admission of Shares and TVR
30th Apr 202610:30 amRNSIssue of Equity
22nd Apr 20261:00 pmRNSPurchase of Own Securities
10th Apr 202612:10 pmRNSIssue of Equity
31st Mar 20261:30 pmRNSTotal Voting Rights
31st Mar 20261:05 pmRNSUtilisation of over-allotment facility
31st Mar 20269:00 amRNSIssue of Equity
6th Mar 202611:16 amRNSDirector/PDMR Shareholding
6th Mar 202611:15 amRNSDirector/PDMR Shareholding
6th Mar 202611:12 amRNSDirector/PDMR Shareholding
5th Mar 202610:07 amRNSIssue of Equity
27th Feb 20269:00 amRNSNotification of Admission of Shares and TVR
13th Feb 20269:00 amRNSIssue of Equity
11th Feb 20261:09 pmRNSNet Asset Value
30th Jan 20267:00 amRNSNotification of Admission of Shares and TVR
20th Jan 20269:00 amRNSIssue of Equity
13th Jan 20267:00 amRNSDirectorate change
31st Dec 20257:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
16th Dec 20252:15 pmRNSIssue of Equity and TVR
28th Nov 20257:00 amRNSTotal Voting Rights
21st Nov 20259:16 amRNSDirector/PDMR Shareholding
21st Nov 20259:15 amRNSDirector/PDMR Shareholding
21st Nov 20259:00 amRNSIssue of Equity
17th Nov 20253:15 pmRNSHalf-Year Report
13th Nov 202510:29 amRNSChange of Registered Office
12th Nov 20254:44 pmRNSDividend Declaration
23rd Oct 202512:25 pmRNSIssue of Equity and TVR
25th Sep 20255:42 pmRNSResult of AGM
19th Sep 20255:19 pmRNSPurchase of Own Securities
9th Sep 20253:51 pmRNSPublication of Prospectus
21st Aug 202510:40 amRNSNet Asset Value per Share as at 30 June 2025
25th Jun 20252:15 pmRNSAnnual Financial Report - Replacement
25th Jun 202512:51 pmRNSIntention to Launch an Offer for Subscription
25th Jun 202512:47 pmRNSAnnual Financial Report
27th May 202512:07 pmRNSIssue of Equity
24th Apr 20252:35 pmRNSIssue of Equity
15th Apr 20255:46 pmRNSDirector/PDMR Shareholding
7th Apr 202512:43 pmRNSDirector/PDMR Shareholding
7th Apr 202512:43 pmRNSDirector/PDMR Shareholding
7th Apr 20257:00 amRNSIssue of Equity
31st Mar 20256:10 pmRNSIssue of Equity
20th Mar 202512:19 pmRNSDirector/PDMR Shareholding
20th Mar 202512:18 pmRNSDirector/PDMR Shareholding
19th Mar 202511:40 amRNSIssue of Equity
12th Mar 20257:00 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.